André Araújo de Medeiros Silva

Dr. André Araújo de Medeiros Silva

Coloproctology, Hospital Santa Lucia, Brasília, Distrito Federal, Brazil
orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 December 2024 in Journal of Personalized Medicine
Verified
Journal Article
Open access
PDF file
OFOswaldo De Moraes Filho
Oswaldo De Moraes Filho
Bruno Augusto Alves MartinsBruno Augusto Alves Martins
Bruno Augusto Alves Martins
André Araújo de Medeiros SilvaAndré Araújo de Medeiros Silva
André Araújo de Medeiros Silva
ASAntonio Carlos Nóbrega dos Santos
Antonio Carlos Nóbrega dos Santos
RARomulo Medeiros de Almeida
Romulo Medeiros de Almeida
JSJOÃO BATISTA DE SOUSA Sousa
JOÃO BATISTA DE SOUSA Sousa
Aim: The purpose of the study was to identify potential differences between patients with right colon cancer and left colon cancer in epidemiological, clinical presentation, pathological, and surgical results in addition to the impact of the sidedness on disease-free survival (DFS) and overall survival (OS). Method: Patients with a diagnosis of colon cancer stages I-IV between 2010 and 2020 were identified from a prospective database in a tertiary single center. Right and left-sided cancer were compared regarding epidemiological, clinical presentation, pathological, and surgical results. Survival analysis was conducted using the Kaplan–Meier method and adjusted hazard ratios for mortality (OS) and disease-free survival (DFS) were obtained using Cox proportional hazards regression. Results: The right colon group included 82 (31%) patients and the left colon group 182 (69%). After adjusted analysis, RCC presented less bleeding (RP: 0.31; CI: 0.18–0.56; p: 0.0001) and change in bowel habits (RP: 0.60; CI: 0.41–0.87; p: 0.0069). A laparotomy approach was more performed in LCC (RP: 0.64; CI: 0.47–0.86; p: 0.0029). Regarding pathological results, RCC had more poorly differentiated tumors (RP: 0.81; CI: 0.70–0.94; p: 0.05). In the adjusted analysis, there was no difference in survival for right-sided compared to left-sided colon cancer: the hazard ratios were 1.36 (CI 95%: 0.61–3.01; p: 0.4490) for OS and 2.04 (CI: 0.91–4.59; p: 0.0814) for DFS. Conclusions: In this population-based cohort, we found no impact of colon cancer sidedness on OS and DFS. RCC presented less differentiated tumors and LCC presented more bleeding and change in bowel habits.
1

1 January 2026 in Radiologia Brasileira
Verified
Journal Article
Open access
PNPriscilla Ornellas Neves
Priscilla Ornellas Neves
André Araújo de Medeiros SilvaAndré Araújo de Medeiros Silva
André Araújo de Medeiros Silva
Magnetic resonance imaging (MRI) is the gold-standard imaging modality for evaluating perianal fistulas, playing a pivotal role in characterizing fistula anatomy and guiding optimal surgical strategies. Appropriate preoperative MRI assessment can significantly reduce recurrence rates and minimize the risk of complications, such as fecal incontinence. This article reviews the most relevant information that an MRI report should contain to aid effective surgical decision-making for perianal fistulas. These features influence therapeutic choices, including decisions regarding the suitability of techniques like fistulotomy, ligation of the intersphincteric fistula tract (LIFT), video-assisted anal fistula treatment (VAAFT), fistula-tract laser closure (FiLaC), and advancement flaps. The emerging role of three-dimensional (3D) modeling from MRI data is also discussed, highlighting its potential to enhance surgeons’ spatial understanding of complex fistulous anatomy, thereby improving surgical planning, reducing operative time, and ultimately improving outcomes. However, the generation of accurate 3D models depends on meticulous image segmentation and interpretation by experienced radiologists. Future research directions, including the integration of 3D models with intraoperative navigation and standardized assessment of inflammatory activity, are also addressed in this review.

4 February 2026 in Current Oncology
Verified
Journal Article
Open access
PDF file
OFOswaldo Moraes Filho
Oswaldo Moraes Filho
Bruno Augusto Alves MartinsBruno Augusto Alves Martins
Bruno Augusto Alves Martins
André Araújo de Medeiros SilvaAndré Araújo de Medeiros Silva
André Araújo de Medeiros Silva
RARomulo Medeiros de Almeida
Romulo Medeiros de Almeida
ASAntonio Carlos Nobrega dos Santos
Antonio Carlos Nobrega dos Santos
JSJOÃO BATISTA DE SOUSA Sousa
JOÃO BATISTA DE SOUSA Sousa
Colorectal cancer is predominantly a disease of older adults, yet age-related treatment decisions remain controversial. While chronological age is often used as a criterion for surgical eligibility, it remains unclear whether age alone is an independent predictor of surgical and oncological outcomes. This study evaluated whether age is a significant determinant of outcomes in colorectal cancer patients undergoing surgical resection. This retrospective comparative study analyzed 262 patients (193 younger than 70 years, 69 aged ≥ 70 years) diagnosed with colorectal cancer stages I–IV between 2014 and 2021 at a tertiary single center. Survival analysis was conducted using Kaplan–Meier method and Cox proportional hazards regression. Elderly patients had higher ASA classification (p = 0.0270), higher hypertension prevalence (p < 0.0001), higher ICU admission rates (50.7% vs. 21.2%, p < 0.0001), and longer hospital stays (12.6 vs. 7.5 days, p = 0.0016). However, elderly patients presented with earlier-stage disease (Stage I + II: 64.2% vs. 46.1%, p = 0.0108). After adjustment for confounding factors, age did not significantly impact overall survival (HR = 1.33; 95%CI: 0.54–3.26; p = 0.5375) or disease-free survival (HR = 1.61; 95%CI: 0.79–3.29; p = 0.1939). Despite differences in clinical presentation and pathological findings, age itself was not an independent predictor of survival outcomes. These findings suggest that treatment decisions in elderly colorectal cancer patients should be informed by individual patient physiology and disease stage rather than chronological age alone.

11 November 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
André Araújo de Medeiros SilvaAndré Araújo de Medeiros Silva
André Araújo de Medeiros Silva
Bruno Augusto Alves MartinsBruno Augusto Alves Martins
Bruno Augusto Alves Martins
OFOswaldo Moraes Filho
Oswaldo Moraes Filho
ASAntonio Carlos Nóbrega dos Santos
Antonio Carlos Nóbrega dos Santos
CBCamila Oliveira Barbosa
Camila Oliveira Barbosa
JSJOÃO BATISTA DE SOUSA Sousa
JOÃO BATISTA DE SOUSA Sousa
Early-onset colorectal cancer (EOCRC) may differ clinically and oncologically from later-onset disease. This retrospective cohort study compared surgically treated patients with stage I–IV colorectal adenocarcinoma diagnosed at age < 50 vs. ≥ 50 years at a tertiary center between 2010 and 2020. Clinical, pathological, perioperative, and oncological outcomes were compared. Survival was evaluated using Kaplan–Meier analysis and Cox proportional hazards regression. Of 434 patients, 78 (17.97%) were aged < 50 years and 356 (82.03%) were aged ≥ 50 years. Mean (SD) follow-up was 35.59 (16.27) months. Patients aged < 50 years had shorter hospital stays (prevalence ratio [PR], 0.11; 95% CI, 0.01–0.21; p = 0.0336) but exhibited a higher prevalence of undifferentiated tumors (PR, 2.38; 95% CI, 1.18–4.78; p = 0.0147) and a 93% higher risk of recurrence (hazard ratio [HR], 1.93; 95% CI, 1.00–3.72; p = 0.0483) than those aged ≥ 50 years. No significant age-related difference was observed in overall survival, symptom–to–diagnosis interval, or pathological stage. EOCRC was associated with undifferentiated histology and a higher risk of disease recurrence. Further studies incorporating treatment information and molecular tumor characteristics are needed to clarify the independent prognostic significance of age in EOCRC.

31 October 2026 in Annals of Coloproctology
Verified
Journal Article
Open access
André Araújo de Medeiros SilvaAndré Araújo de Medeiros Silva
André Araújo de Medeiros Silva
PNPriscilla Ornellas Neves
Priscilla Ornellas Neves
CMCarlos Ramon Silveira Mendes
Carlos Ramon Silveira Mendes
JAJuliana Gurgel Faria Araújo
Juliana Gurgel Faria Araújo
JPJoana Carolina Saraiva de Paula
Joana Carolina Saraiva de Paula
LPLarissa Martins Peluso
Larissa Martins Peluso

1 December 2025 in Journal of Coloproctology
Verified
Conference Paper
Open access
André Araújo de Medeiros SilvaAndré Araújo de Medeiros Silva
André Araújo de Medeiros Silva
BMBruno Augusto Alves Martins
Bruno Augusto Alves Martins
OFOswaldo de Moraes Filho
Oswaldo de Moraes Filho
ASAntonio Carlos Nóbrega dos Santos
Antonio Carlos Nóbrega dos Santos
CBCamila Oliveira Barbosa
Camila Oliveira Barbosa
JSJoão Batista Sousa
João Batista Sousa
Autor correspondente: ANDRE ARAUJO DE MEDEIROS SILVA - andreams2@gmail.com O câncer colorretal (CCR) é o terceiro tumor mais incidente globalmente e o segundo mais letal. Embora a idade seja um fator de risco preponderante, com a maioria dos casos ocorrendo após os 50 anos, observa-se um preocupante aumento da incidência em indivíduos com menos de 50 anos, que tendem a apresentar a doença em estágios mais avançados, com características histológicas mais agressivas. Este estudo retrospectivo teve como objetivo avaliar as características epidemiológicas, clínicas, anatomopatológicas e os desfechos oncológicos em pacientes com adenocarcinoma colorretal com menos de 50 anos (n = 78, 17,97%) e compará-los com aqueles com 50 anos ou mais (n = 356, 82,03%), tratados em um hospital terciário entre 2010 e 2020. Foram analisados 434 pacientes. Os resultados mostraram que o grupo de pacientes mais jovens apresentou menor estratificação de risco cirúrgico (ASA I e II: 80,77% vs. 67,89%, p = 0,0243) e menor frequência de comorbidades como tabagismo, hipertensão arterial e diabetes mellitus. Não houve diferença estatística na localização do tumor, IMC, consumo de álcool, sintomas de apresentação ou tempo entre o início dos sintomas e o diagnóstico. Em relação aos desfechos clínico-cirúrgicos, o grupo mais jovem teve menor tempo de internação hospitalar (p = 0,0336), e a necessidade de UTI não se mostrou associada à idade após ajuste para comorbidades. A análise anatomopatológica ajustada pela localização, o tipo histológico indiferenciado foi significativamente mais prevalente em pacientes com menos de 50 anos [PR = 2,38 (IC 95%: 1,18; 4,78; p = 0,0147)], sugerindo uma doença mais agressiva nesta população. Apesar de não haver diferença estatisticamente significativa na sobrevida global (p = 0,2921), a sobrevida livre de doença foi pior para pacientes mais jovens, com um risco de recidiva 93% maior (HR = 1,14; IC 95%: 0,67; 1,95; p = 0,0685), embora sem significância estatística no modelo multivariado. Fatores como ASA elevado, etilismo e invasão perineural foram associados a menor sobrevida global. Níveis elevados de CEA pré-operatório e invasão perineural foram associados a menor sobrevida livre de doença. Conclui-se que, embora o estágio patológico e o tempo entre os sintomas e o diagnóstico tenham sido semelhantes em ambos os grupos, pacientes jovens com adenocarcinoma colorretal apresentaram maior prevalência de tumores indiferenciados e um risco mais elevado de recidiva da doença, o que pode indicar um pior prognóstico para o CCR de início precoce. Article published online: 26 May 2026 © 2026. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/) Thieme Revinter Publicações Ltda. Rua Rego Freitas, 175, loja 1, República, São Paulo, SP, CEP 01220-010, Brazil